Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Emergency Coronary Artery Bypass Graft in Acute Myocardial Infarction

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04572061
Recruitment Status : Completed
First Posted : October 1, 2020
Last Update Posted : October 1, 2020
Sponsor:
Information provided by (Responsible Party):
Saud Al Babtain Cardiac Center

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
A retrospective study investigating the early outcome of emergency CABG post MI in patients who were operated at Saud Al Babtain Cardiac Center.

Condition or disease
Acute Myocardial Infarction

Detailed Description:
A retrospective study of surgical patients who underwent Coronary Artery Bypass Graft for Acute Myocardial Infarction between December 2013 and February 2018 determining outcomes on morbidity and mortality.
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 109 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Emergency Coronary Artery Bypass Graft in Acute Myocardial Infarction
Actual Study Start Date : February 7, 2017
Actual Primary Completion Date : October 31, 2017
Actual Study Completion Date : July 31, 2018

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. STEMI and Emergency CABG [ Time Frame: 1 year ]
    Evaluate patients the early outcome of emergency CABG post MI.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   17 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All adult patients admitted at Saud Al Babtain Cardiac Center with post cardiogenic shock who underwent CABG.
Criteria

Inclusion Criteria:

  • Patients with post cardiogenic shock who underwent CABG
  • =/> 17 years old

Exclusion Criteria:

  • Patients other than post cardiogenic shock who underwent CABG or any cardiac surgeries
  • <17 years old
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04572061


Locations
Layout table for location information
Saudi Arabia
Saud Al Babtain Cardiac Center
Dammam, Saudi Arabia, 31463
Sponsors and Collaborators
Saud Al Babtain Cardiac Center
Investigators
Layout table for investigator information
Principal Investigator: Ahmed Attiea, MD Saud Al Babtain Cardiac Center
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Saud Al Babtain Cardiac Center
ClinicalTrials.gov Identifier: NCT04572061    
Other Study ID Numbers: SBCC-2017-04
First Posted: October 1, 2020    Key Record Dates
Last Update Posted: October 1, 2020
Last Verified: September 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Saud Al Babtain Cardiac Center:
CABG
Additional relevant MeSH terms:
Layout table for MeSH terms
Myocardial Infarction
Infarction
Emergencies
Ischemia
Pathologic Processes
Necrosis
 Disease Attributes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases